Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
06/2005
06/02/2005WO2005049805A2 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast
06/02/2005WO2005049804A2 Engineering enzymes through genetic selection
06/02/2005WO2005049802A2 Anti-hydroxylase antibodies and uses thereof
06/02/2005WO2005049800A2 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
06/02/2005WO2005049799A2 Chimeric chemokine receptor polypeptides
06/02/2005WO2005049798A2 Chromosome 5 genetic variants related to dyslexia
06/02/2005WO2005049797A2 Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof
06/02/2005WO2005049796A2 Chromosome 5 genetic variants related to dyslexia
06/02/2005WO2005049795A2 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration
06/02/2005WO2005049794A2 Methods of characterizing infectious bursal disease virus
06/02/2005WO2005049793A2 Methods and compositions for combinatorial approaches to cancer gene therapy
06/02/2005WO2005049792A2 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
06/02/2005WO2005049791A2 Identification of reagents for the diagnosis and study of francisella
06/02/2005WO2005049790A2 Skn-1 and gsk-3 genes and proteins
06/02/2005WO2005049788A2 Reprogramming of somatic cell nuclei
06/02/2005WO2005049787A2 Compositions and methods for in vitro sorting of molecular and cellular libraries
06/02/2005WO2005033268A8 Stem cells for clinical and commercial uses
06/02/2005WO2005033265A9 Optimized multi-epitope constructs and uses thereof
06/02/2005WO2005028625A3 Consensus/ancestral immunogens
06/02/2005WO2005017115A3 Cord blood-derived hematopoietic progenitor cells
06/02/2005WO2005014785A3 Conditionally-immortalized hematopoietic progenitor cell lines
06/02/2005WO2005012483A3 Vpr selective rnai agents and methods for using the same
06/02/2005WO2005012480A3 Systems and methods for separating and concentrating regenerative cells from tissue
06/02/2005WO2005005613A3 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
06/02/2005WO2005005606A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
06/02/2005WO2004097002A3 SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF
06/02/2005WO2004096984A3 Preservation of rna in a biological sample
06/02/2005WO2004094601A3 Methods of treating pin1 associated disorders by covalent modification of active site residues
06/02/2005WO2004083393A3 Enhanced protein thermostability and temperature resistance
06/02/2005WO2004081187A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
06/02/2005WO2004076648A3 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response.
06/02/2005WO2004076633A3 Hypoxia inducible vegf plasmid for ischemic disease
06/02/2005WO2004076625A3 Method of identifying plant cells transformed with a gene
06/02/2005WO2004070003A3 Methods for selecting and screening for trasformants
06/02/2005WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
06/02/2005WO2004065545A3 Diagnosis and prognosis of breast cancer patients
06/02/2005WO2004007691A3 Herbicide-resistant plants, and polynucleotides and methods for providing same
06/02/2005US20050119214 Nuclease resistant double-stranded ribonucleic acid
06/02/2005US20050118678 Modified polypeptide comprising amphipathic alpha -helical structure for use in prevention and treatment of infection and cell proliferative disorders
06/02/2005US20050118643 Specific binding agents to hepatocyte growth factor
06/02/2005US20050118617 Solid phase synthesis; microarrays
06/02/2005US20050118606 Methods for identifying risk of breast cancer and treatments thereof
06/02/2005US20050118561 Compositions and methods for propagation of neural progenitor cells
06/02/2005US20050118150 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
06/02/2005US20050118117 Methods for identifying risk of melanoma and treatments thereof
06/02/2005CA2545893A1 Anti-hydroxylase antibodies and uses thereof
06/02/2005CA2545886A1 Methods of characterizing infectious bursal disease virus
06/02/2005CA2538342A1 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
06/01/2005EP1534865A2 Methods and compositions for determining methylation profiles
06/01/2005EP1534859A2 Methods of detecting sequence differences
06/01/2005EP1534066A2 Alpha(1,3)-galactosyltransferase null cells, methods of selecting and alpha(1,3)-galactosyltransferase null swine produced therefrom
06/01/2005EP1451291A4 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1621094A Gene transfer for regulating smooth muscle tone
05/2005
05/26/2005WO2005047487A2 Motoneuronotrophic factor gene sequences
05/26/2005WO2005047486A2 Biological production of tetradehydrolycopene
05/26/2005WO2005047485A2 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
05/26/2005WO2005047484A2 Biomarkers for alzheimer's disease
05/26/2005WO2005047483A2 Renta: an hiv immunogen and uses thereof
05/26/2005WO2005047482A2 Real time electronic cell sensing systems and applications for cell-based assays
05/26/2005WO2005047481A2 Novel sequences encoding hapatitis c virus glycoproteins
05/26/2005WO2005047480A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005WO2005047479A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
05/26/2005WO2005047478A2 Compositions and methods for regulation of tumor necrosis factor-alpha
05/26/2005WO2005047477A2 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
05/26/2005WO2005047476A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
05/26/2005WO2005047475A2 Regulation of cell membrane-mediated effects
05/26/2005WO2005047474A2 Nucleic acid detection method having increased sensitivity
05/26/2005WO2005047473A2 Single vector dual gene therapy for pulmonary hypertension
05/26/2005WO2005047472A2 Increasing seed threonine content through alteration of threonine aldolase activity
05/26/2005WO2005047471A2 Improved fret efficiency methods
05/26/2005WO2005047470A2 Intercalator fret donors or acceptors
05/26/2005WO2005047469A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
05/26/2005WO2005047468A2 Improved methods for detecting and measuring specific nucleic acid sequences
05/26/2005WO2005047466A2 Apparatus and method for tissue engineering
05/26/2005WO2005047465A2 Method and antisense compound for potentiating anti-cancer agents
05/26/2005WO2005047464A2 Cell culture tool and method
05/26/2005WO2005047463A2 Hcv replicons containing ns5b from genotype 2b
05/26/2005WO2005047461A2 Polypeptide display libraries and methods of making and using thereof
05/26/2005WO2005047460A2 Long-wavelength fps
05/26/2005WO2005047457A2 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
05/26/2005WO2005047455A2 Methods for the production of apolipoproteins in transgenic plants
05/26/2005WO2005026316A3 Alphavirus vaccines
05/26/2005WO2005021711A3 Approach for obtaining monoclonal antibodies to cell surface proteins
05/26/2005WO2004085620A3 Novel attached cell lines
05/26/2005WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
05/26/2005WO2004070008A3 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
05/26/2005US20050114918 System and method of embryo delivery for manufactured seeds
05/26/2005US20050113565 Pegylated factor VII glycoforms
05/26/2005US20050113564 Chimeric receptors with 4-1BB stimulatory signaling domain
05/26/2005US20050113328 Method and antisense compound for potentiating anti-cancer agents
05/26/2005US20050113325 Linked/conjugated to lipid, fatty acid, and/or sterol; for inhibiting cancer cell proliferation
05/26/2005US20050113292 Protein mimetic for preventing HIV-1 entry to host cells of living subject through membrane fusion, wherein HIV-1 contains envelope glycoprotein gp41 that has plurality of peptides in pre-hairpin state, comprising at least two monomeric peptide strands and interstrand linker coupling peptide strands
05/26/2005US20050112763 Control forming within genome of cells, histone protein; induce methylation
05/26/2005US20050112746 Protein embedding in three-dimensional structure; detecting binding with ligand; computer analysis
05/26/2005US20050112742 Heat resistance; stable pH; Thermus culture product
05/26/2005US20050112734 Forming chemical intermediate, such as 2-ketogluconate, for ascorbic acid
05/26/2005US20050112726 Biosynthetic gene cluster for leptomycins
05/26/2005US20050112724 Pseudopterosin production
05/26/2005US20050112723 Mammalian cell lines specifically deficient in O-linked glycosylation
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 100